Table 1.
Demographic, clinical and intraoperative characteristics of the study population (n = 45)
| Number or Value | |
|---|---|
| Gender (male/female) | 27/18 |
| Age, years (median (IQR)) | 62 (54–73) |
| ASA score | |
| 1 | 2 |
| 2 | 21 |
| 3 | 22 |
| 4 | 0 |
| Neoadjuvant chemotherapy (yes/no) | 9/36 |
| Operating room time, min (median (IQR)) | 488 (450–551) |
| Estimated blood loss, ml (median (IQR)) | 900 (600–2000) |
| Length of stay, days (median (IQR)) | 13 (8–19) |
| Types of procedurea | |
| PPPD | 18 |
| cWP | 15 |
| TP | 7 |
| DP | 5 |
| Type of venous reconstruction | |
| Interponate | 37 |
| Patch | 8 |
| Concomitant arterial resection (yes/no) | 6/39 |
| Clavien–Dindo ≥ III complication | 16 |
| Anticoagulation therapy | |
| LMWH 1–3 months after surgery (yes/no) | 37/8 |
| Lifelong aspirin (yes/no) | 21/24 |
| Lifelong coumadin for other indications | 4 |
| <30 day thrombosis/no or low flow at reconstruction site | |
| Thrombosis | 2 |
| No/low flow | 2 |
| In-hospital mortality | 2 |
a
PPPD, pylorus-preserving pancreatoduodenectomy; cWP, classic Whipple; TP, total pancreatectomy; DP, distal pancreatectomy.